Earlier, Venezuelan Vice President Delcy Rodriguez said the country was interested in approval of that vaccine.
"A few hours ago, we received a batch of the Russian vaccine EpiVacCorona to begin research in Venezuela," Jimenez wrote on Twitter, adding that it is based on a synthetic peptide antigen technology, which allows the best antibodies to be stimulated in vaccinated people.
Hace unas horas, recibimos una dotación de la vacuna rusa EpiVacCorona para iniciar estudios en Venezuela.— Gabriela Jiménez (@Gabrielasjr) March 30, 2021
Esta vacuna se basa en una tecnología de antígenos péptidos sintéticos, la cual permite estimular los mejores anticuerpos en las personas vacunadas.#CienciaEsSoberanía pic.twitter.com/wZiaM0lvtW
In January, Russian consumer watchdog Rospotrebnadzor said that the first and second stages of clinical stages showed that EpiVacCorona has 100 percent immune efficiency.
In total, Russia has three registered vaccines for coronavirus prevention: Sputnik V, EpiVacCorona and CoviVac. The first batch of Russia's Sputnik V vaccine was shipped to the South American country for testing in October 2020. The regular deliveries of the vaccine kicked off in early February.